Entasis Therapeutics Holdings Inc. (ETTX) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
09M18M26M35M44M52M61M70MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

EBITDA

EBITDA
-60M-52M-45M-37M-30M-22M-15M-7M1Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

EPS

Revenue Variation (%)

Income Variation (%)

Operating Income VariationNet Income Variation
088175262350438525612700Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Revenue YoY Variation (%)

Income YoY Variation (%)

Operating Income YoY VariationNet Income YoY Variation
0100200300400500600700800Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Price-to-Earning Ratio

P/E Ratio
-4-3-3-2-2-1-001Q1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0375K750K1M2M2M2M3M3MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Per Share Metrics

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
09M18M26M35M44M52M61M70MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
04M8M11M15M19M22M26M30MQ1 2021Q2 2021Q3 2021Q4 2021Q1 2022
🏦 Balance Sheet
📈 Key Metrics